אמילי
abic marketing ltd, israel - ethinylestradiol; gestodene - טבליות מצופות - gestodene 0.075 mg; ethinylestradiol 0.02 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.
שלי
abic marketing ltd, israel - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.03 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.
ארימידקס
taro international ltd, israel - anastrozole - טבליות מצופות פילם - anastrozole 1.0 mg - anastrozole - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
אנסטרול
perrigo israel agencies ltd - anastrozole 1 mg - film coated tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
פמוזול
perrigo israel agencies ltd - letrozole 2.5 mg - film coated tablets - letrozole - • femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .
לטרוזול דקסל
dexcel ltd, israel - letrozole - טבליות מצופות פילם - letrozole 2.5 mg - letrozole - letrozole - letrozole - dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. letrozole - dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
לוסטר פינק קונדישינינג נו ליי רילקסר סופר (קרם החלקה רילקסר)
חומרים ותכשירים קוסמטיים - החלקת שיער
לוסטר פינק קונדישינינג נו ליי רילקסר סופר (חומר מפעיל)
חומרים ותכשירים קוסמטיים - חומר הפעלה
לוסטר פינק קונדישינינג נו ליי רילקסר (מרכך מחדיר לחות)
חומרים ותכשירים קוסמטיים - מרכך שיער בחפיפה
לוסטר פינק קונדישינינג נו ליי רילקסר סופר (קרם לחות עם ויטמינים ומסנן קרינה)
חומרים ותכשירים קוסמטיים - הגנה בפני השמש ושימון קל לשיער